ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.62 Cr | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹4.62 Cr |
Mar2024 | ₹4.52 Cr |
Mar2023 | ₹1.96 Cr |
Mar2022 | ₹1.63 Cr |
Mar2021 | ₹4.03 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4.62 Cr | 2.17 | |
Mar2024 | ₹4.52 Cr | 130.38 | |
Mar2023 | ₹1.96 Cr | 20.22 | |
Mar2022 | ₹1.63 Cr | -59.46 | |
Mar2021 | ₹4.03 Cr | - |
Compare Contingent Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹531.8 Cr | -0.8% | 11.3% | -27.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | -0.8% |
11.3% |
-27.1% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses